These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9794937)

  • 1. Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans.
    Schütz E; Shipkova M; Armstrong VW; Oellerich M
    Hepatology; 1998 Nov; 28(5):1439-40. PubMed ID: 9794937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoethylglycinexylidide (MEGX)-test. A test for the assessment of prognosis before and after liver transplantation].
    Reichel C; Wienkoop G; Nacke A; Spengler U
    Dtsch Med Wochenschr; 1995 Feb; 120(6):179-83. PubMed ID: 7851289
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of determination of monoethylglycinexylidide (MEGX)--as a liver function test in hepatology and liver transplantation].
    Kupcová V
    Bratisl Lek Listy; 1999 Jan; 100(1):49-53. PubMed ID: 10492998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared.
    Schütz E; Shipkova M; Niedmann PD; Wieland E; Armstrong VW; Oellerich M
    Clin Chem; 1998 Jun; 44(6 Pt 1):1269-74. PubMed ID: 9625052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary gas chromatographic method for the measurement of small concentrations of monoethylglycinexylidide and lidocaine in plasma.
    Laroche N; Leneveu A; Roux A; Flouvat B
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):375-81. PubMed ID: 9824255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of monoethylglycinexylidide (MEGX) in clinically healthy dogs.
    Neumann S; Frenz M; Streit F; Oellerich M
    Can J Vet Res; 2011 Oct; 75(4):317-20. PubMed ID: 22468031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
    Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
    J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age on plasma MEGX concentrations.
    Orlando R; Palatini P
    Br J Clin Pharmacol; 1997 Aug; 44(2):206-8. PubMed ID: 9278213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
    Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoethylglycinexylidide test for grading of liver cirrhosis.
    Fabris L; Jemmolo RM; Toffolo G; Paleari D; Viaggi S; Rigon M; Casagrande F; Lirussi F; Strazzabosco M; Cobelli C; Okolicsanyi L
    Aliment Pharmacol Ther; 1999 Jan; 13(1):67-75. PubMed ID: 9892881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine metabolite formation as a measure of perioperative liver function.
    Shimanuki K; Sakurabayashi I; Miyata M; Kiyozaki H; Suzuki W; Kashii A; Seo N
    Surg Today; 1993; 23(4):315-9. PubMed ID: 8318785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEGX (monoethylglycinexylidide): a novel in vivo test to measure early hepatic dysfunction after hypovolemic shock.
    Chandel B; Shapiro MJ; Kurtz M; Rana WU; Matthews M; Jellinek M; Baue AE
    Shock; 1995 Jan; 3(1):51-3; discussion 54-5. PubMed ID: 7850580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.